author-photo

Robert K. Stuart

Medical University of South Carolina

234

Papers

6931

Citations

Citation Trend

Filter By

Papers (170) Sort By

Journal Conference Others

Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial

2021 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (4)
Phase 1b Study of Lower-Dose CPX-351 Plus Venetoclax As First-Line Treatment for Patients with AML Who Are Unfit for Intensive Chemotherapy: Preliminary Safety and Efficacy Results

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
MDS-335: Ivosidenib (IVO) in Patients with IDH1-Mutant Relapsed/Refractory Myelodysplastic Syndrome (R/R MDS): Updated Enrollment for the MDS Sub-Study

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance).

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (1)
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.

2020 Organic Process Research & Development
Show All
- Source
- Cite
- Save
Citations (4)
Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma

2020 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (4)
MDS-265: Ivosidenib (IVO) in Patients with IDH1-Mutant Relapsed/Refractory Myelodysplastic Syndrome (R/R MDS): Updated Enrollment of a Phase 1 Dose Escalation and Expansion Study

2020 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (2)
A randomized phase II trial of CX-01 with standard therapy in elderly patients with acute myeloid leukemia (AML).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (8)
Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study.

2019 Blood Advances
Show All
- Source
- Cite
- Save
Citations (35)